Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Thornberry Nancy −$262K Director sold 37% of stake
  2. Schuth Alexander O. −$65K COFO and Secretary sold <1% of stake
  3. Chin Peter Scott −$37K Chief Medical Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2018-10-02 Schuth Alexander O. COO and Secretary Option exercise · Stock Option (right to buy) −5,859 56,641
2018-10-01 Watts Ryan J. President and CEO Sale −18,333 $21.72 $398K 2,747,638
2018-10-01 Ho Carole Chief Medical Officer Sale −17,500 $21.72 $380K 183,390
2018-09-04 Ho Carole Chief Medical Officer Sale −17,500 $19.05 $333K 200,890
2018-09-04 Watts Ryan J. President and CEO Sale −18,333 $19.06 $349K 2,765,971
2018-08-29 Ho Carole Chief Medical Officer Sale −17,500 $18.04 $316K 218,390
2018-08-29 Watts Ryan J. President and CEO Sale −18,334 $18.05 $331K 2,784,304
2018-08-20 Schuth Alexander O. COO and Secretary Grant or award · Restricted Stock Units +11,286 11,286
2018-08-20 Ho Carole Chief Medical Officer Grant or award · Restricted Stock Units +11,286 11,286
2018-08-20 Krognes Steve E. CFO and Treasurer Grant or award · Restricted Stock Units +11,286 11,286
2018-06-22 Schuth Alexander O. COO and Secretary Option exercise +5,918 $5.28 $31K 5,918
2018-06-22 Schuth Alexander O. COO and Secretary Option exercise · Stock Option (right to buy) −5,918 119,082
2018-06-13 NELSEN ROBERT Director Grant or award · Stock Option (right to buy) +27,830 27,830
2018-06-13 Tessier-Lavigne Marc Director Grant or award · Stock Option (right to buy) +27,830 27,830
2018-06-13 FLATLEY JAY T Director Grant or award · Stock Option (right to buy) +27,830 27,830
2018-06-13 Schenkein David P Director Grant or award · Stock Option (right to buy) +27,830 27,830
2018-06-13 Cole Douglas G. Director Grant or award · Stock Option (right to buy) +27,830 27,830
2018-06-13 SATO VICKI L Director Grant or award · Stock Option (right to buy) +27,830 27,830
2018-03-16 Klein Peter S Director Grant or award · Stock Option (right to buy) +37,954 37,954
2018-02-26 Ho Carole Chief Medical Officer Grant or award · Stock Option (right to buy) +180,000 180,000

Page 47 of 53 · 1,053 trades